Nygard Biotec
Nygard Biotec

The Movie

Peter Nygards 4 Step Strategy:

Step 1: Obtaining the right technology

University of Oregon Scientist, Dr. Shoukhrat Mitalipov explains, “It’s been 15 years since we invented the embryonic stem cell, and no one has been able to figure out how to use it.”   The procedure inserts adult human DNA into an unfertilised human egg, so that the growing stem cells can be used to treat serious disease and ageing.

 

“The way in which these stem cell lines were derived is from embryos that were created in the process of In Vitro Fertlisation (IVF), and, in fact, there are hundreds of thousands of these embryos that are simply being discarded,” said Dr. Francis Collins, Director of the US National Institute of health.

Step 2: Finding the perfect setting

After lengthy international travels, Mr. Nygard settled in the Bahamas for good reason many years ago.  Recognised by its popularity among A-class celebrities and the rich and famous, the Bahamas is a celebrated holiday destination with beautiful weather, a welcoming economy and an ever-friendly culture.  He believes that his new home would be perfect for both his business and the Bahamian people.

Step 3: Educating the law-makers

Mr Nygard needed the Bahamian government to willingly adopt supportive legislation for his stem cell studies.  This was a critical step in the progression of his extensive plans for research. He says that Bahama’s current Prime Minister Perry Christie "showed tremendous courage and political savviness to guide this through the legislature”.

 

PM Christie states in the video above that:“Two years ago Peter Nygård called me to say that if your country is prepared to pass legislation, I will find a way to bring scientists who I have retained. I am prepared to have them come into the Bahamas.”

 

The stem cell bill was passed in January of 2014 and was the first time the Bahamas’ ‘Medical Act’ had been revised in over 12 years. 

Step 4: Planing and construction of the scientific facilities

The construction of a multi-million dollar facility which develops both genomic sequencing and embryonic stem-cell technology would be the first of its kind anywhere in the world. 

 

While importing the most advanced stem cell technologies available, the aim is to also expand research into commercial genome sequencing (GS). This is described as the mapping of an organism’s entire DNA sequence, potentially used to predict one’s risk of developing a range of genetically inherited pathologies. 

Stem Cell News: Science Daily

Innate reaction of hematopoietic stem cells to severe infections (Thu, 20 Jul 2017)
>> Read more

Using a pig model to study chronic diseases may help minimize drug failure rate (Thu, 20 Jul 2017)
>> Read more

Reducing inflammation protects stem cells during wound repair (Thu, 20 Jul 2017)
>> Read more

'Nano-in-micro' stem cell delivery could rescue blood flow after injury (Wed, 19 Jul 2017)
>> Read more

Genome therapy could lead to new treatment for life-threatening blood disorders (Mon, 17 Jul 2017)
>> Read more

Advance furthers stem cells for use in drug discovery, cell therapy (Fri, 14 Jul 2017)
>> Read more

Using a microRNA to shift the makeup of glioblastoma subtypes (Thu, 13 Jul 2017)
>> Read more

Hormone replacement therapies help breast cancer grow, spread (Wed, 12 Jul 2017)
>> Read more

Neural stem cells steered by electric fields in rat brain (Tue, 11 Jul 2017)
>> Read more

Stem cell-based therapy for targeting skin-to-brain cancer (Mon, 10 Jul 2017)
>> Read more

New technology to manipulate cells could help treat Parkinson's, arthritis, other diseases (Mon, 10 Jul 2017)
>> Read more

How high-fat diet impacts colorectal cancer (Thu, 06 Jul 2017)
>> Read more

Genetic DJ: Growing cells remix their genes (Wed, 05 Jul 2017)
>> Read more

Freeze-frames of enzymes in action have implications for a new cancer treatment concept (Mon, 03 Jul 2017)
>> Read more

First 'haploid' human stem cells could change the face of medical research (Wed, 28 Jun 2017)
>> Read more

Print Print | Sitemap
© Nygard Biotech